Professor, Internal Medicine, University of Michigan Medical School
Gastroenterology
Dr. Robert J. Fontana, MD
|
|
Give Review
Robert Fontana is an expert in the field of Gastroenterology. He researched medicine at University of Michigan Medical School. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Robert J. Fontana is a published MD as well. He has 92 publications published. The latest was: Amoxicillin-Clavulanate-Induced Liver Injury.
Publications
- Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
- Quality of care metrics in chronic hepatitis B.
- Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN).
- Clinical and histologic features of azithromycin-induced liver injury.
- Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity.
- Transpapillary Gallbladder Stents can Stabilize or Improve Decompensated Cirrhosis in Patients Awaiting Liver Transplantation.
- Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade.
- Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation.
- Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis.
- Malignant Infiltration of the Liver Presenting as Acute Liver Failure.
- 2-year outcomes in Initial survivors with Acute Liver failure: Results from a Prospective, Multicenter Study.
- Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.
- Outcomes of Patients with Chronic Hepatitis B Who do not Meet Criteria for Antiviral Treatment at Presentation.
- ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
- Carbamoyl phosphate synthatase-1 (CPS1) is a rapid turnover biomarker in mouse and human acute liver injury.
- Clinical features, diagnosis, and natural history of drug-induced liver injury.
- Reliability of causality assessment for drug, herbal and dietary supplement hepatoxicity in the Drug-Induced Liver Injury Network (DILIN).
- Epstein-Barr Virus (EBV) Related Acute Liver Failure: A Case Series from the US Acute Liver Failure Study Group.
- Relationship Between Characteristics of Medications and Drug-Induced Liver Disease Phenotype and Outcome.
- Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives.
- Drug-drug interactions with oral anti-HCV agents and Idiosyncratic Hepatotoxicity in the Liver Transplant setting.
- Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients.
- IL-28B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: a meta-analysis.
- Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.
- A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7?years.
- Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C.
- Presentation and Outcomes with Clinically Apparent Interferon Beta Hepatotoxicity.
- Drug-induced Liver Injury Caused by Intravenously Administered Medications: The Drug-induced Liver Injury Network Experience.
- Liver Injury from Tumor Necrosis Factor-? Antagonists: Analysis of 34 Cases.
- Prophylactic anticoagulation in cirrhotics: a paradox for prime time?
- Clinical yield of diagnostic ERCP in orthotopic liver transplant recipients with suspected Biliary complications.
- Meta-analysis: IL-28B genotype and sustained viral clearance in HCV genotype 1 patients.
- Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
- YKL-40 genetic polymorphisms and the risk of liver Disease progression in patients with advanced fibrosis due to chronic hepatitis C.
- Patient knowledge about disease self-management in Cirrhosis.
- Decision making in liver transplant selection committees: a multicenter study.
- Incidence and Risk Factors of Hepatocellular Carcinoma Recurrence After Liver Transplantation in the MELD Era.
- Short and Long-Term Outcomes in Patients with Acute Liver Failure Due to Ischemic Hepatitis.
- Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
- Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
- Detection and management of latent tuberculosis in liver transplant patients.
- Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity.
- Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.
- Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers.
- Making the world a safer place.
- Renal outcomes after liver transplantation in the model for end-stage liver Disease era.
- An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
- Cirrhotic patients with a transjugular intrahepatic portoSystemic shunt undergoing major extrahepatic surgery.
- Side effects of long-term oral antiviral therapy for hepatitis B.
- Hepatitis B: a "GLOBAL" health challenge.
- Assessment of the newly diagnosed patient with chronic hepatitis B virus infection.
- Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.
- Acute liver failure including acetaminophen overdose.
- Acute liver failure due to drugs.
- Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury.
- Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
- Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy.
- Hepatitis C in organ donors and heart transplant recipients.
- Clinical relevance of cognitive scores in hepatitis C patients with advanced fibrosis.
- Management of drug-resistant chronic hepatitis B.
- Immune thrombocytopenic purpura following liver transplantation: a case series and review of the literature.
- Optimizing outcomes in hepatitis C: is treatment beyond 48 weeks ever justified?
- Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.
- Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus Disease in adult liver transplant recipients.
- Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy.
- Acute liver failure due to amoxicillin and amoxicillin/clavulanate.
- Acute hepatitis associated with alosetron (Lotronex).
- Prognosis of hepatocellular carcinoma: comparison of 7 staging Systems in an American cohort.
- Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.
- Nonresponders to hepatitis C virus antiviral therapy: pegylated interferons and beyond.
- Clinical significance of hepatitis B virus genotypes, variants, and mutants.
- Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice.
- The patient's perspective in hepatitis C.
- Controversies in the management of hepatitis C patients with advanced fibrosis and Cirrhosis.
- Management of decompensated HBV Cirrhosis: lamivudine and beyond.
- A simple noninvasive index can predict both significant fibrosis and Cirrhosis in patients with chronic hepatitis C.
- Are we ready for marginal hepatitis B core antibody-positive living liver donors?
- Renal transplantation in HBsAg+ patients: is lamivudine your "final answer"?
- Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver Disease in american patients.
- Management of patients with decompensated HBV Cirrhosis.
- Cytokine gene polymorphisms in chronic hepatitis B: a step up the immunology ladder.
- Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
- NAFLD may be a common underlying liver Disease in patients with hepatocellular carcinoma in the United States.
- Noninvasive monitoring of patients with chronic hepatitis C.
- Combination of HBIG and lamivudine-resistant mutations: a formula for trouble?
- Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy.
- Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C.
- High-dose interferon alfa-2b and ribavirin in patients previously treated with interferon: results of a prospective, randomized, controlled trial.
- Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury.
- Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance.
- Amoxicillin-Clavulanate-Induced Liver Injury.
Schools
University Of Michigan Medical School
Northwestern University
University Mi Med School
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Hemorrhoidectomy or Excision of Anal Tags
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Emblem Health
- First Health (Coventry Health Care) PPO
- Frontpath Health Coalition
- Golden Rule
- Health Alliance
- Preferred PPO
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Paramount
- PHP-Physicians Health Plan
- Priority PPO
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
- Worker's Compensation WC
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
McGaw Medical Center of Northwestern University -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1700968237 | |
| NPPES Provider LastName | FONTANA | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 481095362 | |
| NPPES Provider State | MI | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 1249.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700968237 |
| Last Name Of The Provider | FONTANA |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. John Del Valle, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacy B. Menees, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jorge A. Marrero, MD |
|
|
Dr. Radoslav Coleski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony T. Debenedet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chung Owyang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Scheiman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert W. Shaffer, MD |
|
|
Dr. Marisa A. Spencer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mina K. Oh, MD |